Consun Pharmaceutical Group 配当と自社株買い

配当金基準チェック /46

Consun Pharmaceutical Group配当を支払う会社であり、現在の利回りは6.93%で、収益によって十分にカバーされています。

主要情報

6.9%

配当利回り

-2.0%

バイバック利回り

総株主利回り	4.9%
将来の配当利回り	7.4%
配当成長	16.9%
次回配当支払日	n/a
配当落ち日	n/a
一株当たり配当金	HK$0.600
配当性向	52%

最近の配当と自社株買いの更新

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12

Recent updates

Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

Oct 02

Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

Sep 26

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18

決済の安定と成長

配当データの取得

安定した配当: 1681の配当金支払いは、過去10年間変動性が高かった。

増加する配当: 1681の配当金は過去10年間にわたって増加しています。

配当利回り対市場

Consun Pharmaceutical Group 配当利回り対市場

1681 配当利回りは市場と比べてどうか？
セグメント	配当利回り
会社 (1681)	6.9%
市場下位25% (HK)	3.2%
市場トップ25% (HK)	8.0%
業界平均 (Pharmaceuticals)	3.8%
アナリスト予想 (1681) (最長3年)	7.4%

注目すべき配当: 1681の配当金 ( 6.93% ) はHong Kong市場の配当金支払者の下位 25% ( 3.22% ) よりも高くなっています。

高配当: 1681の配当金 ( 6.93% ) はHong Kong市場の配当金支払者の上位 25% ( 8.01% ) と比較すると低いです。

株主への利益配当

収益カバレッジ: 1681の配当金は、合理的な配当性向 ( 52.3% ) により、利益によって賄われています。

株主配当金

キャッシュフローカバレッジ: 1681は合理的な現金配当性向 ( 53.7% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。

Consun Pharmaceutical Group 配当と自社株買い

配当金 基準チェック /46

主要情報

最近の配当と自社株買いの更新

Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on 20 September 2024

Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023

Consun Pharmaceutical Group Limited Announces Special Dividend, Payable on 21 June 2024

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

Upcoming dividend of HK$0.15 per share at 6.2% yield

Recent updates

Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

First half 2024 earnings released: EPS: CN¥0.50 (vs CN¥0.44 in 1H 2023)

Investor sentiment improves as stock rises 15%

Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

CEO & Executive Chairman recently bought HK$5.4m worth of stock

First half dividend of HK$0.30 announced

Consun Pharmaceutical Group Limited Announces Executive Changes

Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on 20 September 2024

Consun Pharmaceutical Group Limited to Report First Half, 2024 Results on Aug 21, 2024

Consun Pharmaceutical Group Limited Receives Notice of Approval for Clinical Trial of Drug for SK-08 Tablet

CEO & Executive Chairman recently bought HK$7.7m worth of stock

Consun Pharmaceutical Group Limited Announces Board and Committee Changes

Chief Scientist & Executive Director recently sold HK$8.4m worth of stock

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

New minor risk - Shareholder dilution

Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023

Insider recently sold HK$62m worth of stock

Consun Pharmaceutical Group Limited Announces Special Dividend, Payable on 21 June 2024

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consun Pharmaceutical Group Limited, Annual General Meeting, May 31, 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

Consun Pharmaceutical Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Consun Pharmaceutical Group Limited Announces Management Changes

First half 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.37 in 1H 2022)

Upcoming dividend of HK$0.15 per share at 6.2% yield

First half 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.37 in 1H 2022)

Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023

Consun Pharmaceutical Group Limited to Report First Half, 2023 Results on Aug 24, 2023

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.30 per share at 6.0% yield

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.37 (vs CN¥0.31 in 1H 2021)

Consun Pharmaceutical Group Limited to Report First Half, 2022 Results on Aug 26, 2022

Investor sentiment deteriorated over the past week

Consun Pharmaceutical Group Limited, A Wholly-Owned Subsidiary of Consun Pharmaceutical (Horgos) Co., Ltd Holds A Trial Production Ceremony in Plant No. 8, Area A05, Horgos Comprehensive Bonded Zone, Yili Kazakh

Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.20 per share

Full year 2021 earnings released: EPS: CN¥0.74 (vs CN¥0.61 in FY 2020)

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 17 June 2022

Less than half of directors are independent

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Investor sentiment improved over the past week

Upcoming dividend of HK$0.10 per share

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

First half 2021 earnings released: EPS CN¥0.31 (vs CN¥0.25 in 1H 2020)

Investor sentiment improved over the past week

Chairman of the Board Yubao An has left the company

Upcoming dividend of HK$0.20 per share

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.094 in FY 2019)

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.094 in FY 2019)

Investor sentiment improved over the past week

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Consun Pharmaceutical Group Limited to Report Fiscal Year 2020 Results on Mar 23, 2021

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

New 90-day high: HK$3.40

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

配当金基準チェック /46